Market and industry insiders are
forecasting the national legal demand
for cannabis to increase to
$22 Billion by 2020.
There are many advantages that the ancillary sector has, such as it avoids regulatory hurdles, it enables Inter-State Commerce, and it allows brand expansion.
The introduction of Adult Use in CO and WA have resulted in a 70% year over year compounded growth rate.
The ancillary cannabis market grew
161.2% in 2016. Consulting increased
737%, investment / M&A up 366%, and consumption devices
Cannabis-related companies raised more than $734 million between January 1st and April 21st, 2017. Resulting in a 7X increase from the $108 million raised in the same period last year according to Arcview.
Arcadian and partners predict a 3-5 times multiple expansion into ancillary revenue. This would result in the California ancillary market alone increasing to a minimum of $36 billion by 2018.
1 in 8 adults consider themselves regular consumers. Communities benefit from job creation, addictions, criminal justice reform, and public health.
Halfway into 2018, M&A deals have doubled this year than the same period of last. Public & private cannabis companies in the US & Canada raised more than $1.3 billion during the same period in 2017.
Medical cannabis also represents a scalable solutions to the opiate epidemic, which is costing the U.S. more than $500 billion in economic productivity each year.